Cystadenoma of spermatic cord resembling ovarian serous epithelial tumour of low malignant potential: Immunohistochemical study suggesting Müllerian differentiation

Histopathology

Volumn 28, Issue 1, 1996, Pages 77-80

  McCluggage, W G ^a,c   Shah, V ^a   Nott, C ^b   Clements, B ^c   Wilson, B ^d   Hill, C M ^d  

^a ROYAL GROUP OF HOSPITALS   (United Kingdom)

^b Department of Morbid Anatomy   (United Kingdom)

^c ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Borderline tumour; Cystadenoma; Spermatic cord

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; CASE REPORT; CYSTADENOMA; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OVARY TUMOR; PRIORITY JOURNAL; SPERMATIC CORD; ULTRASTRUCTURE;

AGED; CA-125 ANTIGEN; CELL DIFFERENTIATION; CILIA; CYSTADENOCARCINOMA, SEROUS; CYSTADENOMA; CYSTS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; MULLERIAN DUCTS; OVARIAN NEOPLASMS; SPERMATIC CORD; TESTICULAR NEOPLASMS;

EID: 0030061665     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.272317.x     Document Type: Article

References (12)

1. Young RH. Scully RE, Testicular and paratesticular tumors and tumor-like lesions of ovarian common epithelial and Mullerian types. Am. J. Clin. Pathol. 1986: 86; 146-152.
2. Brito CG, Bloch T, Foster RS, Bihrle R. Testicular papillary cystadenomatous tumor of low malignant potential: a case report and discussion of the literature. J. Urol. 1988: 139; 378-379.
3. Remmele W, Kaiserling E, Zerban U, Hildebrand U, Bennek M, Jacobi-Nolde P et al. Serous papillary cystic tumor of borderline malignancy with focal carcinoma arising in testis: case report with immunohistochemical and ultrastructural observations. Hum. Pathol. 1992: 23; 75-79.
4. Axiotis CA. Intratesticular serous papillary cystadenoma of low malignant potential: an ultrastructural and immunohistochemical study suggesting Mullerian differentiation. Am. J. Surg. Pathol. 1988: 12; 56-63.
5. De Nictolis M, Tommasoni S, Fabris G, Prat J. Intratesticular serous cystadenoma of borderline malignancy. A pathological, histochemical and DNA content study of a case with long term follow-up. Virchows Archiv. A Pathol Anat. 1993: 423; 221-225.
6. Blumberg HM, Hendrix LE. Serous papillary adenocarcinoma of the tunica vaginalis of the testis with metastasis. Cancer 1991: 67; 1450-1453.
7. Friedlander ML, Russell P, Taylor IW, Hedley DW, Tattersall MHN. Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy. Pathology 1984: 16; 301-306.
8. Wang NS. Electron microscopy in the diagnosis of pleural mesotheliomas. Cancer 1973: 31; 1046-1054.
9. Bast RC Jr, Feeney M, Lazarus H, Nadler LH, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest. 1981: 68; 1331-1337.
10. Leake J, Woolas RP, Daniel J, Oram DH, Brown CL. Immunocytochemical and serological expression of CA125: a clinico-pathological study of 40 malignant ovarian epithelial tumours. Histopathology 1994: 24; 57-64.
11. Teilum G. Special tumors of ovary and testis. Comparative pathology and histological identification. Philadelphia: JB Lippincott, 1976: 466-469.
12. Lauchlan SC. The secondary Mullerian system. Obstet. Gynecol. Surv. 1972: 27; 133-146.